METHYL 2-CHLORO-6-(TRIFLUOROMETHYL)PYRIDINE-4-CARBOXYLATE, 95.0%, 250mg

9-Acetylantracene, 95.0%, 10g

butyl[(3-methylphenyl)methyl]amine hydrochloride, 95.0%, 10g

4-Chloro-5-(trifluoromethyl)pyrimidin-2-amine, 95.0%, 250mg

3-Benzyloxazolidine, 95%, 1g

N-(3-bromobenzyl)-2-butanamine hydrochloride, 95.0%, 5g

3,5-Difluorophenylacetic Acid>98.0%(GC)(T)5g

Tetrabutylammonium Tetrafluoroborate>98.0%(N)25g

Ultrasonic device series D, 5.4 l, D 60 1 piece

(2S,3S,4R)-2-Aminooctadecane-1,3,4-triol, 95.0%, 25g

Ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)propanoate, 98%, 250mg

5-Chloro-2-methyl-2,3-dihydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrol-1-one, 98%, 1g

Dialysis systems Spectra/Por® Float-A-Lyzer® G2 Filling volume 5 ml, 100000 dalton(s), 12 Piece(s)